Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$2.45 USD
+0.06 (2.51%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $2.46 +0.01 (0.41%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Taysha Gene Therapies, Inc. [TSHA]
Reports for Purchase
Showing records 1 - 20 ( 25 total )
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
GAN Data Continues to Paint Compelling Picture for TSHA-120
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Gene Therapy 101: Deliver the Target, Express the Protein - TSHA on Right Path
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Angelman Syndrome Investor Event - Key Highlights, Takeaways
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Discovery Collaboration Continues to Create Optionality for TSHA
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Investor Event Showcases Earlier-Stage Efforts in Rett Syndrome
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
CLN1 Disease Investor Event - Key Highlights, Takeaways
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Company: Taysha Gene Therapies, Inc.
Industry: Medical - Generic Drugs
Taking A Closer Look Under The Hood - Manufacturing Day Highlights
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L